Literature DB >> 2278885

Definition of the activities and properties of c-myc required to inhibit cell differentiation.

S O Freytag1, C V Dang, W M Lee.   

Abstract

Previous studies have shown that high levels of c-myc inhibit cell differentiation. The goal of this study was to define the activities and properties of c-myc that are necessary and/or sufficient for this effect. A series of mutant human c-myc genes were stably transfected into the 3T3-L1 preadipocyte cell line and assayed for their capacity to block differentiation into adipocytes. Results of the differentiation tests were then correlated with other known activities and properties of the mutants. Our studies show that the ability of c-myc to inhibit 3T3-L1 cell differentiation requires its transforming activity, and the ability of c-myc to bind sequence-nonspecific DNA and to form oligomers is not sufficient for this effect. Thus, the ability of c-myc to inhibit cell differentiation may be central to its role as a transforming oncogene.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2278885

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  22 in total

1.  BAF53 forms distinct nuclear complexes and functions as a critical c-Myc-interacting nuclear cofactor for oncogenic transformation.

Authors:  Jeonghyeon Park; Marcelo A Wood; Michael D Cole
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

2.  An amino-terminal c-myc domain required for neoplastic transformation activates transcription.

Authors:  G J Kato; J Barrett; M Villa-Garcia; C V Dang
Journal:  Mol Cell Biol       Date:  1990-11       Impact factor: 4.272

3.  Transcriptional suppression of cellular gene expression by c-Myc.

Authors:  B S Yang; T J Geddes; R J Pogulis; B de Crombrugghe; S O Freytag
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

4.  Myc inhibits p27-induced erythroid differentiation of leukemia cells by repressing erythroid master genes without reversing p27-mediated cell cycle arrest.

Authors:  Juan C Acosta; Nuria Ferrándiz; Gabriel Bretones; Verónica Torrano; Rosa Blanco; Carlos Richard; Brenda O'Connell; John Sedivy; M Dolores Delgado; Javier León
Journal:  Mol Cell Biol       Date:  2008-10-06       Impact factor: 4.272

5.  A minimal regulatory region maintains constitutive expression of the max gene.

Authors:  M A Peters; K G Sollenberger; T L Kao; E J Taparowsky
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

6.  Overexpression of Myc suppresses CCAAT transcription factor/nuclear factor 1-dependent promoters in vivo.

Authors:  B S Yang; J D Gilbert; S O Freytag
Journal:  Mol Cell Biol       Date:  1993-05       Impact factor: 4.272

7.  Cell cycle regulation of the c-Myc transcriptional activation domain.

Authors:  A Seth; S Gupta; R J Davis
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

8.  Gain of MYC underlies recurrent trisomy of the MYC chromosome in acute promyelocytic leukemia.

Authors:  Letetia Jones; Guangwei Wei; Sabina Sevcikova; Vernon Phan; Sachi Jain; Angell Shieh; Jasmine C Y Wong; Min Li; Joshua Dubansky; Mei Lin Maunakea; Rachel Ochoa; George Zhu; Thelma R Tennant; Kevin M Shannon; Scott W Lowe; Michelle M Le Beau; Scott C Kogan
Journal:  J Exp Med       Date:  2010-11-08       Impact factor: 14.307

Review 9.  O-GlcNAc cycling: implications for neurodegenerative disorders.

Authors:  Brooke D Lazarus; Dona C Love; John A Hanover
Journal:  Int J Biochem Cell Biol       Date:  2009-03-27       Impact factor: 5.085

10.  TRRAP-dependent and TRRAP-independent transcriptional activation by Myc family oncoproteins.

Authors:  Mikhail A Nikiforov; Sanjay Chandriani; Jeonghyeon Park; Iulia Kotenko; Dina Matheos; Anna Johnsson; Steven B McMahon; Michael D Cole
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.